HT
LABU icon

Headlands Technologies’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Headlands Technologies’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,218
Closed -$69.3K – 988
2025
Q2 		$69.3K Buy
+1,218
New +$64.6K 0.01% 713
2024
Q3 		– Sell
-596
Closed -$67.6K – 1380
2024
Q2 		$67.6K Buy
+596
New +$63.8K 0.01% 722

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Headlands Technologies's LABU Position: Q3 2025 in Review

Headlands Technologies sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2025, closing a stake of 1,218 shares — an estimated $69.3K sold.

Headlands Technologies first reported a position in LABU in Q2 2024 and held it in 2 quarters. The position peaked at $69.3K in Q2 2025. 39 funds tracked by Wall St. Rank hold LABU as of Q3 2025.

  • Headlands Technologies reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 1,218 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2025, an estimated $69.3K.
  • Headlands Technologies first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2024 and held it in 2 quarters.
  • Headlands Technologies's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $69.3K in Q2 2025.
  • 39 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.